Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells

Circulation Research

Volumn 81, Issue 2, 1997, Pages 249-257

  Saward, Laura ^a   Zahradkas, Peter ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Angiotensin II; Immunofluorescent microscopy; LY294002; Phosphatidylinositol 3 kinase; Smooth muscle cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DNA; PHOSPHATIDYLINOSITOL KINASE; RNA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0030858836     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.81.2.249     Document Type: Article

References (50)

1. Dzau VJ. Vascular angiotensin pathways: a new therapeutic target. J Cardiovasc Pharmacol. 1987;10:S9-S16.
2. Shirai H, Takahashi K, Katada T, Inagami T. Mapping of G protein coupling sites of the angiotensio II type 1 receptor. Hypertension 1995;25:726-730.
3. 2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci. 1995;16:223-225.
4. Kambayashi Y, Takahashi K, Bardhan S, Inagami T. Molecular structure and function of angiotensin type 2 receptor. Kidney Int. 1994;46:1502-1504.
5. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268:7388-7345.
6. 2+-dependent signaling. Circ Res. 1995;76:1-15.
7. Srivastava AK. Protein tyrosine phosphorylation in cardiovascular system. Mol Cell Biochem. 1995;149/150:87-94.
8. Murrero MB, Paxton WB, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylalion of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem. 1994;269:10935-10939.
9. Malarkey K, Belham CM, Paul A, Graham A, McLees A, Scott PH. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem J. 1995;309:361-375.
10. Luttrell LM, van Biesen T, Hawes BE, Koch WJ. Touhara K, Lefkowitz RJ. Gβlγ subunits mediate mitogen-activatcd protein kinase activation by the tyrosine kinase insulin-like growth factor 1 receptor. J Biol Chem. 1995;270:16495-16498.
11. 1A cells. J Biol Chem. 1995;270:19059-19065.
12. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. l995;375:247-250.
13. Varticovski L, Harrison-Findik D, Keeler ML, Šuša M. Role of PI 3-kinase in mitogenesis. Biochim Biophys Acta. 1994;1126:1-11.
14. Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol. 1993;13:7418-7428.
15. Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. Bioessays. 1994;16:565-576.
16. Kelly KL, Rudderman NB. Insulin-stimulated phosphatidylinositol 3-kinase. J Biol Chem. 1993;268:4391-4398.
17. 3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell. 1995;83:821-830.
18. Shepherd PR, Reaves BJ, Davidson HW. Phosphoinositide 3-kinases and membrane traffic. Trends Cell Biol. 1996;6:92-97.
19. Li G, D'Souza-Schorey C, Barbieri MA, Roberts RL, Klippel A, Williams LT, Stahl PD. Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab5. Proc Natl Acad Sci U S A. 1995;92:10207-10211.
20. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241-5248.
21. Yano H, Agatsuma T, Nakanishi S, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fe epsilon-mediated signal transduction. Biochem J. 1995;312:145-150.
22. Sanchez-Margalet V, Goldfine ID, Vlahos CJ, Sung CK. Role of phosphatidylinositol-3-kinase in insulin receptor signalling: studies with inhibitor, LY294002. Biochem Biophys Res Commun. 1994;204:446-452.
23. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994;14:4902-4911
24. Ferby IM, Waga I, Sakanaka C, Kume K, Shimizu T. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J Biol Chem. 1994;269:30485-30488.
25. Petritsch C, Woscholski R, Edelmann HML, Parker PJ, Ballou LM. Selective inhibition of p70 S6 kinase activation by phosphatidylinositol 3-kinase inhibitors. Eur J Biochem. 1995;230:431-438.
26. Ui M, Okada T, Hazeki K, Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci. 1995;20:303-307.
27. Stephens L, Smrcka A, Cooke FT, Jackson TR, Sternweis PC, Hawkins PT. A novel phosphoinositide 3-kinase activity in myeloid-derived cells is activated by G protein βγ subunits. Cell. 1994;77:83-93.
28. Saad MJA, Velloso LA, Carvalho CRO. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J. 1995;310:741-744.
29. Saward L, Zahradka P. Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem. In press.
30. Balla T, Baukal AJ, Guillemette G, Catt KJ. Multiple pathways of inositol polyphosphate metabolism in angiotensin-stimulated adrenal glomerulosa cells. J Biol Chem. 1988;263:4083-4091.
31. Okada T, Sakuma L, Fukui Y, Hazeki O, Ui M. Blockage of chemotactic peptide-induced stimulation of noutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J Biol Chem. 1994;269:3563-3567.
32. Whitman M, Downes PC, Keeler M, Keller T, Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 1988;332:644-646.
33. Šuša M, Keeler M, Varticovski L. Platelet-derived growth factor activates membrane-associated phosphatidylinositol 3-kinase and mediates its translocation from the cytosol. J Biol Chem. 1992;267:22951-22956.
34. Saward L, Zahradka P. The angiotensin type 2 receptor mediates RNA synlhesis in A10 vascular smooth muscle cells. J Mol Cell Cardiol. 1996;28:499-506.
35. Shi Y, Kornovski BS, Savani R, Turley EA. A rapid, multiwell colorimetric assay for chemotaxis. J Immunol Methods. 1993;164:149-154.
36. Kapeller R, Chakrabarti R, Cantley L, Fay F, Corvera S. Internalization of activated platelet-derived growth factor receptor-phosphatidylinositol-3′ kinase complexes: potential interactions with the microtubule cytoskeleton. Mol Cell Biol. 1993;13:6052-6063.
37. Neri LM, Milani D, Bertolso L, Stroscio M, Bertagnolo V, Capitani S. Nuclear translocation of phosphatidylinositol 3-kinase in rat pheochromocytoma PC12 cells after treatment with nerve growth factor. Cell Mol Biol. 1994;40:619-626.
38. 2 receptors mediate smooth muscle cell growth by angiotensin II. J Mol Cell Cardiol. 1995;27:A103. Abstract.
39. Leduc I, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal-adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem. 1995;270:4401-4404.
40. Chen H, Guan J. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1994;91:10148-10152.
41. c-src with endosomal membranes in mammalian fibroblasts. J Cell Biol. 1942;118:321-333.
42. David-Pfeuty T, Nouvian-Dooghe Y. Immunolocalization of the cellular src protein in interphase and mitotic NIH c-src overexpresser cells. J Cell Biol. 1990;111:3097-3116.
43. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994;54:2419-2423.
44. Arcaro A, Wymann MP. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-triphosphate in neutrophil responses. Biochem J. 1993;296:297-30l.
45. Bonser RW, Thompson NT, Randall RW, Tateson JE, Spacey GD, Hodson HF, Garland LG. Domethoxyvirdin and wortmannin block phospholipase C and D activation in the human neutrophil. Br J Pharmacol. 1991;103:1237-1241.
46. 2 activity in Swiss 3T3 cells. J biol Chem. 1995;270:25353-25355.
47. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ. Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem. 1996;271:12133-12136.
48. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr, Abraham RT. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996;15:5256-5267.
49. c-src in vascular smooth muscle cells. Circ Res. 1995;77:1053-1059.
50. Karnitz LM, Sutor SL, Abraham RT. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J Exp Med. 1994;179:1799-1808.